Sonia Jiménez Mola1, César Calvo-Lobo2, Javier Idoate Gil1, Jesús Seco Calvo3,4. 1. Ortogeiatric Unit, Complejo Asistencial Universitario de León (CAULE), León, Spain. 2. Nursing and Physical Therapy Department, Institute of Biomedicine (IBIOMED), Universidad de León, León, Spain. 3. Institute of Biomedicine (IBIOMED), University of León, León, Spain. 4. University of the Basque Country (UPV/EHU), Leioa, Spain.
Abstract
PURPOSE: The aim of the study was to determine the cognitive impairment level influence in descriptive characteristics, comorbidities, complications, and pharmacological features of older adults with hip fracture. DESIGN: Cross-sectional study. METHOD: Five hundred fifty-seven older adults with hip fracture were recruited and divided into cognitive impairment levels (severe/moderate, mild, no impairment). Descriptive characteristics, comorbidities, complications, and pharmacological data were collected. FINDINGS: Significant differences (p < .05, R = .012-.475) between cognitive impairment levels were shown. Shorter presurgery hospital length of stay and lower depression and Parkinson comorbidities; delirium complication; and antidepressants, antiparkinsonians, and neuroleptics use were shown for the no-impairment group. With regard to the cognitive impairment groups, lower presence of cardiopathy and hypertension; higher presence of dementia; antihypertensives, antiplatelets, and antidementia medication; infection/respiratory insufficiency complications; and lower constipation complications were shown. CONCLUSION: Cognitive impairment levels may determine the characteristics, comorbidities, pharmacology, and complications of older adults with hip fracture. CLINICAL RELEVANCE: Cognitive impairment level may impact rehabilitation nursing practice, education, and care coordination.
PURPOSE: The aim of the study was to determine the cognitive impairment level influence in descriptive characteristics, comorbidities, complications, and pharmacological features of older adults with hip fracture. DESIGN: Cross-sectional study. METHOD: Five hundred fifty-seven older adults with hip fracture were recruited and divided into cognitive impairment levels (severe/moderate, mild, no impairment). Descriptive characteristics, comorbidities, complications, and pharmacological data were collected. FINDINGS: Significant differences (p < .05, R = .012-.475) between cognitive impairment levels were shown. Shorter presurgery hospital length of stay and lower depression and Parkinson comorbidities; delirium complication; and antidepressants, antiparkinsonians, and neuroleptics use were shown for the no-impairment group. With regard to the cognitive impairment groups, lower presence of cardiopathy and hypertension; higher presence of dementia; antihypertensives, antiplatelets, and antidementia medication; infection/respiratory insufficiency complications; and lower constipation complications were shown. CONCLUSION:Cognitive impairment levels may determine the characteristics, comorbidities, pharmacology, and complications of older adults with hip fracture. CLINICAL RELEVANCE: Cognitive impairment level may impact rehabilitation nursing practice, education, and care coordination.
Authors: Umile Giuseppe Longo; Sergio De Salvatore; Ilaria Piergentili; Anna Indiveri; Calogero Di Naro; Giulia Santamaria; Anna Marchetti; Maria Grazia De Marinis; Vincenzo Denaro Journal: Int J Environ Res Public Health Date: 2021-02-25 Impact factor: 3.390